EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update

Associazione Italiana per lo Studio del Fegato (AISF)

Digestive and Liver Disease · 2026-05 · 58 (5) · 599-607

DOI: 10.1016/j.dld.2026.02.014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Digestive and Liver Disease, 2026-05. Verfasst von Associazione Italiana per lo Studio del Fegato (AISF). Hauptthemen laut MEDLINE: Metabolic Syndrome, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeNon-alcoholic Fatty Liver DiseaseFatty LiverHumansSemaglutideDiabetes Mellitus, Type 2Glucagon-Like PeptidesDisease ProgressionItalyHypoglycemic AgentsPractice Guidelines as TopicObesityPropionatesChalcones

Stichwörter der Autor:innen

Metabolic-dysfunction associated steatohepatitis (MASH)Metabolic-dysfunction associated steatotic liver disease (MASLD)ResmetiromSemaglutideSteatosisTirzepatide

Substanzen

SemaglutideGlucagon-Like PeptidesHypoglycemic AgentselifibranorPropionatesChalcones

Zitieren

APA

Associazione Italiana per lo Studio del Fegato (AISF) (2026). AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update. Digestive and Liver Disease, 58(5), 599-607. https://doi.org/10.1016/j.dld.2026.02.014

Vancouver

Associazione Italiana per lo Studio del Fegato (AISF). AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update. Digestive and Liver Disease. 2026;58(5):599-607. doi:10.1016/j.dld.2026.02.014

BibTeX
@article{AssociazioneItalianaperloStudiodelFegatoAISF2026,
  author = {Associazione Italiana per lo Studio del Fegato (AISF), Associazione Italiana per lo Studio del Fegato (AISF)},
  title = {AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update},
  journal = {Digestive and Liver Disease},
  year = {2026},
  volume = {58},
  number = {5},
  pages = {599--607},
  doi = {10.1016/j.dld.2026.02.014}
}
Kostenlos starten →